CD8A and stage 5 chronic kidney disease: Previously, a higher amount of CD8+ TEMRA cells has already been shown to correlate not only with CMV seropositivity [20] but also with other comorbidities or adverse health events, such as end-stage renal disease [28], a higher risk for graft failure after kidney transplant [29], or a higher risk for cardiovascular mortality [30].